Goldline

Will market 12 SoloPak generic injectable drugs. The 12 products are: flurouracil, gentamicin sulfate, haloperidol, heparin, hydroxyzine, magnesium sulfate, metoclopramide, nitroglycerin, phenytoin, prochlorperazine edisylate, propranolol, and trimethobenzamide. Twenty-seven different SKUs are part of the deal, which will give Goldine a line of 71 injectable products. "We are committed to being a 'major player' in the institutional marketplace," Goldline said. Firm projects the injectables will generate $ 1 mil. in sales in first year.